Apogee Therapeutics
APGE
APGE
167 hedge funds and large institutions have $2.3B invested in Apogee Therapeutics in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 50 increasing their positions, 59 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
12% less capital invested
Capital invested by funds: $2.62B → $2.3B (-$320M)
15% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 59
Holders
167
Holding in Top 10
4
Calls
$14.3M
Puts
$9.54M
Top Buyers
| 1 | +$36.2M | |
| 2 | +$34.6M | |
| 3 | +$34.4M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$26.2M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$20.5M |
Top Sellers
| 1 | -$17.4M | |
| 2 | -$13.6M | |
| 3 | -$12M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$9.93M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.62M |